| Descriptor English: | Ancitabine | ||||||
| Descriptor Spanish: |
Ancitabina
| ||||||
| Descriptor Portuguese: | Ancitabina | ||||||
| Descriptor French: | Ancitabine | ||||||
| Entry term(s): |
Anhydro-Ara-C Cyclo C Cyclo-C CycloC Cyclocytidine NSC 145,668 NSC 145668 NSC-145,668 NSC-145668 NSC145,668 NSC145668 U 33,624A U 33624A U-33,624A U-33624A U33,624A U33624A |
||||||
| Tree number(s): |
D03.383.742.680.245.453.050 D13.570.065.300.050 D13.570.685.245.453.050 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D003504 | ||||||
| Scope note: | Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Antimetabolites, Antineoplastic |
||||||
| Registry Number: | DO2D32W0VC | ||||||
| CAS Type 1 Name: | 6H-Furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R-(2alpha,3beta,3abeta,9abeta))- | ||||||
| Previous Indexing: |
Anhydrides (1974-1975) Cytarabine (1974-1976) Cytidine (1973) |
||||||
| Public MeSH Note: | 96; was CYCLOCYTIDINE 1977-95 (see under CYTARABINE 1977-90) |
||||||
| History Note: | 96; was CYCLOCYTIDINE 1977-95 (see under CYTARABINE 1977-90) |
||||||
| DeCS ID: | 3524 | ||||||
| Unique ID: | D003504 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1991/01/01 | ||||||
| Date of Entry: | 1976/04/13 | ||||||
| Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Ancitabine
- Preferred
NSC-145,668
- Narrower
U-33,624A
- Narrower
Cyclo-C
- Narrower
| Concept UI |
M0005461 |
| Scope note | Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action. |
| Preferred term | Ancitabine |
| Entry term(s) |
Anhydro-Ara-C Cyclocytidine |
| Concept UI |
M0376273 |
| Preferred term | NSC-145,668 |
| Entry term(s) |
NSC 145,668 NSC 145668 NSC-145668 NSC145,668 NSC145668 |
| Concept UI |
M0372336 |
| Preferred term | U-33,624A |
| Entry term(s) |
U 33,624A U 33624A U-33624A U33,624A U33624A |
| Concept UI |
M0005462 |
| Preferred term | Cyclo-C |
| Entry term(s) |
Cyclo C CycloC |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey